ADMA Biologics Inc (ADMA) — Cash Flow Reinvestment Rate
ADMA Biologics Inc (ADMA) has a Cash Flow Reinvestment Rate of 0.04x as of March 2026, reinvesting $2.54 Million (capex $2.54 Million ) from operating cash flow of $58.25 Million. Check ADMA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ADMA Biologics Inc Cash Flow Reinvestment Rate (2023–2025)
Historical reinvestment intensity for ADMA Biologics Inc across 3 annual periods. Explore ADMA Biologics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for ADMA Biologics Inc (2023–2025)
Year-by-year capital reinvestment analysis for ADMA Biologics Inc. For live market cap and broader valuation context, see ADMA market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | $22.57 Million | $50.40 Million | $22.57 Million | ▲ +210.0% |
| 2024 | 0.14x | $17.15 Million | $118.67 Million | $8.57 Million | ▼ -89.7% |
| 2023 | 1.40x | $12.30 Million | $8.80 Million | $4.98 Million | — |